Posttraumatic Stress Disorder
Conditions
Interventions
Group 1: Narrative Exposure Therapy for Children (KIDNET), 11 sessions
Group 2: Treatment as Usual (TAU) within the German Health System
Sponsors
Universität Bielefeld
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: • being a refugee allocated to the community close to one of the participating centers but not necessarily with a permanent permit to stay • PTSD diagnosis according to CAPS-CA-5 • Age 10-18 years • Informed consent obtained from participant (if participant is =16) or participant and caregiver/legal guardian (if participant is <16)
Exclusion criteria
Exclusion criteria: • Acute risk of harm of self or others requiring inpatient treatment • Clinical signs of acute psychotic disorder • Clinical signs of mental retardation which would prevent effective psychotherapy • Concurrent psychotherapeutic treatment • Anxiolytic treatment with benzodiazepines as this medication is known to interfere with exposure-based psychotherapy (other medication is allowed and will be monitored). • High alcohol or drug consumption (= 2-3 days of consumption per week) represents an exclusion criterion if participants cannot assure their preparedness and confidence to control their consumption in favor of the treatment they will receive in the framework of the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in PTSD symptom severity from the diagnostic interview before treatment initiation to the follow-up assignments after 6 and 12 months. PTSD symptoms will be measured at each assessment by a structured clinical interview by expert clinicians using the Clinician-Administered PTSD Scale for DSM-5 – Child/Adolescent Version (CAPS-CA-5; Pynoos et al., 2015). The change in PTSD Symptoms will be evaluated by a mixed linear model. | — |
Secondary
| Measure | Time frame |
|---|---|
| The following continuous secondary outcomes will be assessed before treatment (baseline) and at each follow-up assessment (after 6 and 12 months). The change of these secondary outcomes will be also evaluated by mixed linear models. (1) Depressive symptoms and internalizing and externalizing behavior, assessed by the Hopkins symptom checklist-37 for refugee adolescents (HSCL-37A; Bean, Derluyn, Eurelings-Bontekoe, Broekaert, & Spinhoven, 2007), (2) Suicidal ideation, assessed by the Columbia Suicide Severity Rating Scale (C-SSRS; Posner et al., 2011), and (3) Physical health, assessed by 17 items selected from the Screening for Somatoform Symptoms 7 (SOMS-7) based on their frequency and sensitivity to change (Rief & Hiller, 2003). In addition, the rate of participants who still meet the diagnostic criteria of PTSD according to the CAPS-CA-5, as well as the PTSD response rate will be assessed at each follow-up assessment (after 6 and 12 months). The PTSD response rate will be defined as the number of participants who show clinical significant symptom improvement on the CAPS-CA5, according to the reliable change index (RCI). | — |
Countries
Germany
Contacts
Public ContactSarah Wilker
Universität Bielefeld
Outcome results
None listed